---
phase: 14
reviewers: [gemini, claude]
reviewed_at: 2026-04-04T20:42:37Z
plans_reviewed:
  - 14-01-PLAN.md
  - 14-02-PLAN.md
  - 14-03-PLAN.md
---

# Cross-AI Plan Review — Phase 14

## Gemini Review

# Phase 14 Plan Review: Phase 11 Launch and Lineage Audit Closure

Phase 14 is a procedural gap-closure phase designed to address the documentation and traceability deficiencies in Phase 11 as identified by the `v1.1` milestone audit. The plans focus on refreshing test evidence, formalizing the validation record, and authoring the missing verification report.

## Summary
The plans for Phase 14 provide a robust and disciplined approach to closing the audit gaps for Phase 11. By sequencing the work from evidence refresh (Plan 01) to formal verification authoring (Plan 02) and finally to project-wide traceability updates (Plan 03), the phase ensures that requirement completion claims are backed by an explicit, audit-ready proof chain. The focus on "docs-first" closure, while maintaining the option to stop if evidence refresh fails, preserves the integrity of the GSD milestone audit process.

## Strengths
- **Evidence-First Validation**: Plan 01 correctly prioritizes running focused pytest slices to ensure that the audit trail is based on the current state of the repository rather than stale summaries.
- **Direct Alignment with Audit Gaps**: The plans map 1:1 to the specific deficiencies cited in `v1.1-MILESTONE-AUDIT.md` (e.g., creating `11-VERIFICATION.md`, flipping `11-VALIDATION.md` from draft, and updating `REQUIREMENTS.md`).
- **Traceability Integrity**: Plan 03 enforces the rule that requirements should only be marked complete in the master traceability table once the formal verification artifact exists.
- **Operational Clarity**: The proposed structure for `11-VERIFICATION.md` (splitting launch, artifact continuity, and lineage) matches the technical split of the Phase 11 implementation, making the proof easy to follow for future auditors.

## Concerns
- **Evidence Failure (LOW)**: If the focused pytests in Plan 01 Task 1 fail, the phase is designed to stop. While this is correct for audit integrity, it assumes the underlying code hasn't drifted since Phase 11 was shipped. Given the stability of the mock backend, this risk is minimal.
- **Artifact Sync (LOW)**: The plans must ensure that the "residual caveats" mentioned in `11-VERIFICATION.md` do not contradict the "passed" status in `11-VALIDATION.md`. This is mitigated by the `read_first` directives in the tasks.

## Suggestions
- **Consolidated Summary Note**: As suggested in the "Discretion" section of the context, adding a brief note to the end of the `11-VALIDATION.md` file (in Plan 01 Task 2) explaining that it was finalized retroactively by Phase 14 will prevent confusion for anyone looking at the commit history later.

## Risk Assessment: LOW
The risk is low because no new architectural changes or feature logic are being introduced. The work is limited to evidence collection, documentation, and state management. The plans effectively use existing tests and summaries as the "primary source of truth," ensuring a high probability of successful closure.

---

## Claude Review

Claude CLI was invoked with the same prompt, but it did not return a usable
review body in this environment.

- Command used: `claude -p "$(cat /tmp/gsd-review-prompt-14.md)"`
- Outcome: process hung without producing output and was terminated
- Exit status: `143`
- Stdout: empty
- Stderr: empty

This is recorded as a reviewer failure rather than a substantive review.

---

## Codex Review

Skipped intentionally.

The current runtime is already Codex, so invoking Codex again for this review
would not provide an independent cross-AI signal.

---

## Consensus Summary

Cross-review coverage was limited in this run. Gemini returned a substantive
review, Claude did not produce a usable review body, and Codex was skipped to
avoid self-review. That means there is no true multi-review consensus yet.

### Agreed Strengths

No repeated strengths can be claimed across reviewers because only one
substantive external review was returned.

The strongest positive signal from the returned review is:

- The three-wave sequencing is well scoped for an audit-closure phase: refresh
  evidence first, then author the verification artifact, then restore
  traceability.

### Agreed Concerns

No repeated concerns can be claimed across reviewers because only one
substantive external review was returned.

The highest-priority actionable concerns from the returned review are:

- Keep the phase honest about potential evidence drift: if the focused Phase 11
  pytest slices fail, execution should stop rather than paper over the gap.
- Keep `11-VALIDATION.md` and `11-VERIFICATION.md` synchronized so residual
  caveats in the verification report do not undermine the final validation
  status.

### Divergent Views

None observed. Only one substantive external review was available.

### Reviewer Availability Notes

- `gemini` succeeded and returned a full review.
- `claude` was invoked but hung in this local CLI environment.
- `codex` was skipped intentionally because the current session already runs on
  Codex.
